How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

204,641 results for

cancer AND (breast OR prostate OR colon) AND (NOT brain)

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal

the rectum. They include patients with: ulcerative colitis that is unresponsive to medical treatment or who cannot tolerate the treatment; familial adenomatous polyposis; Crohn's disease; or cancer-related problems. An ileostomy is then needed to allow intestinal contents to exit the body through a stoma on the abdominal wall. Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal (IPG642) © NICE 2019. All rights reserved. Subject (...) the colon and rectum are removed, or to modify a pre-existing ileostomy. A pouch incorporating a collar and an isoperistaltic valve is created using the last 60 cm of the ileum. The valve is made by intussuscepting a segment of small bowel and fixing it to the pouch wall with staples. This valve functions in the opposite direction to that in a Kock pouch, ensuring the bowel's normal peristaltic action keeps intestinal contents in the pouch rather than expelling them. The collar is formed by wrapping

2019 National Institute for Health and Clinical Excellence - Interventional Procedures

2. Management of Central Venous Access in Children With Intestinal Failure: A Position Paper From the NASPGHAN Intestinal Rehabilitation Special Interest Group

program, parenteral nutrition (JPGN 2021;72: 474–486) What Is Known Pediatric patients with intestinal failure require long- term central venous access for parenteral nutrition. Lossofcentralvenousaccessisacommonindication for an intestinal transplant. What Is New The present position paper recommends general principlestooptimizecentralvenousaccessmanage- ment of children with intestinal failure. P ediatric intestinal failure (IF) is characterized by the inability of the gastrointestinal tract (...) : National Guideline and Registry Development (VAN- GUARD) Initiative recently published guidelines for the preservation of central venous access in children (6). The objective of the present position paper is to review the current literature and provide recommendations regarding important aspects of CVC management for children with IF. METHODS Relevant literature was reviewed using PubMed/MEDLINE databases applying the following terms: intestinal failure, short bowel syndrome, central venous catheter

2021 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

3. Colon capsule endoscopy (CCE-2) for the detection of colorectal polyps and cancer in adults with signs or symptoms of colorectal cancer or at increased risk of colorectal cancer

Colon capsule endoscopy (CCE-2) for the detection of colorectal polyps and cancer in adults with signs or symptoms of colorectal cancer or at increased risk of colorectal cancer SHTG Advice Statement | 1 Advice Statement 014-18 November 2018 Advice Statement Colon capsule endoscopy (CCE-2) for the detection of colorectal polyps and cancer in adults with signs or symptoms of colorectal cancer or at increased risk of colorectal cancer Advice for NHSScotland Colon capsule endoscopy (CCE-2 (...) ) is not recommended for routine use in NHSScotland for the detection of colorectal polyps and cancer. The clinical effectiveness evidence is currently limited, no relevant published evidence on the cost effectiveness of the technology was identified, and its place in the patient care pathway has still to be established. CCE-2 may however be considered as an additional testing option in patients who are able to undergo the intensive bowel cleansing needed for CCE-2 and who have contraindications for optical

2019 Evidence Notes from Healthcare Improvement Scotland

4. Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT Full Text available with Trip Pro

Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could (...) not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Neither eicosapentaenoic acid nor aspirin reduced the proportion of individuals with any colorectal adenoma recurrence during surveillance in the NHS Bowel Cancer Screening Programme. {{author}} {{($index , , , , , , , , , , & . Mark A Hull 1, * , Kirsty Sprange 2 , Trish Hepburn 2 , Wei

2019 NIHR HTA programme

5. Bowel screening: Scenario: Bowel screening

in stools, changes in bowel habit and abdominal pain) — advice the person to seek urgent medical review if symptoms develop even if they have taken part in screening recently. Negative screening results should not be used to guide investigation of a person presenting with symptoms of bowel cancer. There are major differences in the use of faecal occult blood testing in investigation of symptomatic disease compared to use as a screening test including different threshold levels for abnormal results (...) physical activity (at least moderate intensity for a minimum of 30 minutes five days a week). Basis for recommendation The recommendations on the contribution of primary care to the bowel screening programme are based on clinical guidance The UK NSC recommendation on bowel cancer screening in adults [ ], Diagnosis and management of colorectal cancer. A national clinical guideline [ ], Scottish Bowel Screening Programme - a guide for professionals [ ], Engaging primary care in bowel screening. GP good

2019 NICE Clinical Knowledge Summaries

6. Bowel cancer screening: guidelines for colonoscopy

Bowel cancer screening: guidelines for colonoscopy Bowel cancer screening: guidelines for colonoscopy - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional cookies You can at any time. Hide this message Show (...) or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance Bowel cancer screening: guidelines for colonoscopy This guidance sets out the process for colonoscopy in the NHS bowel cancer screening programme. From: Published: 1 February 2011 Last updated: 18 February 2021, Applies to: England Documents HTML Details This guidance sets out the process for colonoscopy in the NHS bowel cancer screening programme. It replaces the Quality Assurance Guidelines

2021 Public Health England

7. Standards of practice for computed tomography colonography (CTC) Joint guidance from the British Society of Gastrointestinal and Abdominal Radiology and The Royal College of Radiologists

Professional Support and Standards Board on 24 September 2020. 41 Standards of practice for computed tomography colonography (CTC) Joint guidance from the British Society of Gastrointestinal and Abdominal Radiology and The Royal College of Radiologists www.rcr.ac.uk References 1. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics- by-cancer-type/bowel-cancer#heading-Zero (last accessed 14/1/21) 2. www.gov.uk/government/publications/bowel-cancer-screening-imaging-use/ bowel-cancer (...) the British Society of Gastrointestinal and Abdominal Radiology and The Royal College of Radiologists www.rcr.ac.uk Standards overview T able 1. T echnical and process standards Element Minimum requirement Page Before the test Referrals for CTC Sufficient information provided to permit safe bowel preparation 10 Information giving and consent Patient information leaflet provided in advance 10 Bowel preparation Faecal tagging to be used 10 Same-day CTC after incomplete colonoscopy Faecal tagging to be given

2021 Royal College of Radiologists

8. Use of Bowel Preparation in Elective Colon and Rectal Surgery

antibiotics and probiotics as bowel preparation for elective co- lon cancer surgery to prevent infection: prospective random- ized trial. Surgery. 2014;155:493–503. 31. Güenaga KF, Matos D, Wille-Jørgensen P. Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev. 2011;(9):CD001544. 32. Moghadamyeghaneh Z, Hanna MH, Carmichael JC, et al. Na- tionwide analysis of outcomes of bowel preparation in colon surgery. J Am Coll Surg. 2015;220:912–920. 33. Mahajna A, Krausz M (...) colorectal surgery. Br J Surg. 2006;93:427–433. 38. Pittet O, Nocito A, Balke H, et al. Rectal enema is an alternative to full mechanical bowel preparation for primary rectal cancer surgery. Colorectal Dis. 2015;17:1007–1010. 39. Zmora O, Mahajna A, Bar-Zakai B, et al. Colon and rectal sur- gery without mechanical bowel preparation: a randomized pro- spective trial. Ann Surg. 2003;237:363–367. 40. Bucher P, Gervaz P, Soravia C, Mermillod B, Erne M, Morel P. Randomized clinical trial of mechanical bowel

2020 American Society of Colon and Rectal Surgeons

9. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus

for Gastrointestinal Endoscopy 0016-5107/$36.00 https://doi.org/10.1016/j.gie.2019.09.007 228 GASTROINTESTINAL ENDOSCOPY Volume 91, No. 2 : 2020 www.giejournal.orgis ACPO, occurs as a result of alterations in GI motility and can be characterized by a clinical picture suggestive of mechanical obstruction with no demonstrable cause of obstruction noted on imaging. 4 Given that patients with both colon volvulus and ACPO may present with abdominal pain and distention, demo- graphic factors and abdominal cross (...) aspectsofclinicalpractice. INTRODUCTION Large-bowel obstruction accounts for approximately 25% of all intestinal obstructions. 2 Obstruction can be either functional or mechanical in origin. Colonic volvulus is the most common cause of benign mechanical obstruction and accounts for approximately 3.5% of all cases of large-bowel obstruction in the United States and up to 50% in areas such as Africa and the Middle East. 3 Functional bowel obstruction, an example of which Copyrightª 2020 by the American Society

2020 American Society for Gastrointestinal Endoscopy

10. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer

, Narrow Band Imaging International Colorectal Endoscopic; OR, odds ratio; RR, relative risk; USMSTF, US Multi-Society Task Force on Colorectal Cancer. © 2020 by the American College of Gastroenterology, AGA Institute, and the American Society for Gastrointestinal Endoscopy. The American Journal of Gastroenterology: doi: 10.14309/ajg.0000000000001013 Free Metrics Colorectal polyps are the precursors for most colorectal cancers (CRCs). Some colorectal polyps accumulate enough mutations to develop high (...) most often raised by malignant polyps is whether a patient with an endoscopically resected colorectal lesion with submucosal invasion requires surgical resection of the colorectal segment from which the lesion was removed. Some malignant polyps can be managed endoscopically because the risk of residual cancer in the bowel wall and/or adjacent lymph nodes is very low. Other endoscopically resected malignant polyps are best managed by surgical resection because endoscopic resection alone

2021 American College of Gastroenterology

11. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline

disease of the esopha- gus/stomach/duodenum, malignancy, Mallory–Weiss syn- drome, Dieulafoy lesion, “other” diagnosis, or no identifiable cause [1]. This ESGE Guideline focuses on the pre-endoscopic, endoscopic,andpost-endoscopicmanagementofpatientspre- senting with acute nonvariceal upper gastrointestinal hemor- rhage (NVUGIH), specifically peptic ulcer hemorrhage. MAIN RECOMMENDATIONS 1 ESGE recommends in patients with acute upper gastro- intestinal hemorrhage (UGIH) the use of the Glasgow (...) should be re- startedas soon as possible, preferably within 3–5days. Strong recommendation, moderate quality evidence. 3 ESGE recommends that following hemodynamic resusci- tation, early (=24 hours) upper gastrointestinal (GI) endos- copy should be performed. Strong recommendation, high quality evidence. 4 ESGE does not recommend urgent (=12 hours) upper GI endoscopy since as compared to early endoscopy, patient outcomes are not improved. Strong recommendation, high quality evidence. 5 ESGE

2021 European Society of Gastrointestinal Endoscopy

12. DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies Full Text available with Trip Pro

DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies Validate User We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your content. Could not validate captcha. Please try again. Take me to my Content

2020 Journal of Crohn's and Colitis

13. Ischaemic bowel disease

congestive heart failure atherosclerosis previous ileostomy irritable bowel syndrome colonic carcinoma constipation long-term laxative use use of vasopressors, digitalis, cocaine Diagnostic investigations Treatment algorithm ACUTE ONGOING Contributors Authors Clinical Senior Lecturer Honorary Consultant Colorectal Surgeon Department of Surgery and Cancer Imperial College London London UK Disclosures AVR declares that he has no competing interests. Clinical Research Fellow Department of Surgery and Cancer (...) Ischaemic bowel disease Ischaemic bowel disease - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Search Select language Ischaemic bowel disease Last reviewed: December 2019 Last updated: March 2019 Summary Intestinal ischaemia can be classified into three types: acute mesenteric ischaemia, chronic mesenteric ischaemia, and colonic ischaemia. Acute mesenteric ischaemia may also be further subdivided into embolic

2019 BMJ Best Practice

14. Small bowel obstruction

volvulus intestinal atresia foreign body ingestion Diagnostic investigations abdominal x-rays FBC urea electrolyte panel abdominal CT scan upper gastrointestinal x-ray with small bowel follow-through laparotomy laparoscopy abdominal ultrasound abdominal MRI Treatment algorithm ACUTE Contributors Authors Consultant Colorectal Surgeon Department of Coloproctology St. Mark's Hospital London UK Disclosures JTJ declares that he has no competing interests. Surgical Registrar and Clinical Research Fellow St (...) Small bowel obstruction Small bowel obstruction - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Small bowel obstruction Last reviewed: February 2019 Last updated: January 2019 Summary A mechanical disruption in the patency of the gastrointestinal tract. A medical emergency that requires early diagnosis and intervention. Typically presents with the combined symptoms of abdominal pain, bloating, vomiting, and failure

2019 BMJ Best Practice

15. Bowel cancer screening: imaging use

screening: imaging use Information about imaging practice standards for bowel cancer screening of individuals unsuitable for a colonoscopy. Published 1 November 2012 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number: GW-810 HTML Details This publication explains the use of whole colon imaging as an alternative to a colonoscopy as part of the NHS Bowel Cancer Screening Programme ( 14 October 2019 Added new guidelines on CTC imaging in NHS bowel cancer screening. 1 (...) Bowel cancer screening: imaging use Bowel cancer screening: imaging use - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election on 12 December. Guidance Bowel cancer

2019 Public Health England

16. Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer

Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer Oregon Health Authority : Evidence-based Reports Blog : Health Evidence Review Commission : State of Oregon menu Toggle Main Menu Main Navigation close search Search search Submit You are here: Evidence-based Reports Blog menu Site Navigation Evidence-based Reports Blog Full Width Column 1 Select Ablation for Atrial Fibrillation Acellular Dermal Matrix for Post-Mastectomy Breast Reconstruction Compliance (...) ={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/Reporting.aspx' +'?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+ '/_layouts/15/expirationconfig.aspx' +'?ID={ItemId}&List={ListId}'); return false;}}, null); 0x0 0x1 ContentType 0x01 898 BlogTopic Multicomponent Interventions to Improve Screening for Breast, Cervical or Colorectal Cancer

2020 Oregon Health Evidence Review Commission

17. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ

leadtounderuseorpoorresourcingofhealthfacilities involved inprovidingscreeningservices, with consequent failuretofully realizethe potential benefits to patients. Methods In 2017, the European Society of Gastrointestinal Endoscopy (ESGE) Governing Board established a task force (Public Affairs Working Group led by A.S.) to produce a Position Statement concerning the value of endoscopy for screening purposes in GI cancers. The most prevalent digestive cancers (esophageal squamous cellcarcinoma,esophagealadenocarcinoma,gastric carcinoma (...) Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ Position Statement Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Societyof Gastrointestinal Endoscopy (ESGE) Position Statement Authors AdrianSaftoiu 1,2 ,CesareHassan 3 ,MiguelAreia 4,5 ,ManoopS. Bhutani 6 ,RafBisschops 7 ,ErwanBories 8 ,IrinaM. Cazacu 1,6 ,EvelienDekker 9 , PierreH.Deprez 10 ,StephenP.Pereira 11 ,CarloSenore 12 ,RiccardoCapocaccia 13

2020 European Society of Gastrointestinal Endoscopy

18. Endoscopic Removal of Colorectal Lesions—Recommendations by the US Multi-Society Task Force on Colorectal Cancer

in Gastrointestinal Endoscopy, Gastroenterology, and The American Journal of Gastroenterology. Colonoscopy with polypectomy reduces the incidence of and mortality from colorectal cancer (CRC). 1,2 It is the cornerstone of effective prevention. 3 The National Polyp Study showed that removal of adenomas during colonoscopy is associated with a reduction in CRC mortality by up to 50% relative to population controls. 1,2 The lifetime risk to develop CRC in the United States is approximately 4.3%, with 90% of cases (...) GASTROINTESTINAL ENDOSCOPY Volume 91, No. 3 : 2020 www.giejournal.org Endoscopic removal of colorectal lesions Kaltenbach et alhistologic evaluation of resection tissue, as it removes all layers of the colon wall. 116,117 Suggested indications for endoscopic full-thickness resection include lesions 20 mm vs 81.2% for lesions 20 mm (PZ .0038). This may partly re?ect dif?culty assessing whether the lesion margin is fully contained in the cap when the lesion is fully drawn into the cap. Further outcomes studies

2020 American Society for Gastrointestinal Endoscopy

19. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020

389Introduction Colorectal cancer is one of the most common cancers world- wide, particularly in the economically developed world [1]. Large-bowel obstruction caused by advanced colonic cancer occurs in 8%–13% of colonic cancer patients [2–4]. The man- agementof thissevereclinicalconditionhasbeencontroversial [5].Over thelastdecade,manyarticleshavebeenpublishedon the subject of colonic stenting for malignant colonic obstruc- tion, including randomized controlled trials (RCTs) and sys- tematic reviews. Thereby (...) of metastasized colorectal cancer atdiagnosis[9].Colonoscopicnontraversability,i.e.,theinabil- itytoadvancethescopebeyondthetumor,hasbeensuggested as a risk factor for the development of symptomatic bowel ob- struction during treatment with primary chemotherapy [10– 12]. Nevertheless, prophylactic stenting for patients with colo- nicmalignancywithoutevidenceofsymptomaticobstructionis strongly discouraged because of the potential risks associated with colonic stenting. The only absolute contraindication

2020 European Society of Gastrointestinal Endoscopy

20. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer Full Text available with Trip Pro

resection of the colorectal segment from which the lesion was removed. Some malignant polyps can be managed endoscopically because the risk of residual cancer in the bowel wall and/or adjacent lymph nodes is very low. Other endoscopically resected malignant polyps are best managed by surgical resection because endoscopic resection alone is accompanied by a very high risk of residual cancer and/or lymph node metastases. Optimal selection of patients with malignant polyps for endoscopic surveillance vs (...) Multi-Society Task Force on Colorectal Cancer (USMSTF) consists of gastroenterologists with expertise in colorectal neoplasia (ie, CRC and precursor lesions, such as polyps). The American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy are represented. Summary tables and a draft document were circulated to members of the USMSTF and final guidelines were developed by consensus during several joint teleconferences

2020 American Gastroenterological Association Institute

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>